Micaela morelli (22 resultados)

hardcover. Condición: Very Good. no dust jacket as issued No dust jacket. Very Good hardcover with light shelfwear - NICE! Standard-sized.

Condición: Sehr gut. Zustand: Sehr gut | Seiten: 352 | Sprache: Englisch | Produktart: Bücher | Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant.…

Condición: New. In English.

Paperback. Condición: new. Paperback. Immunotherapies for Neurological Disorders Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This bookaddresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant.…

Taschenbuch. Condición: Neu. Neuware - Dairy 4.0: Revolutionizing the Dairy Sector Through Industry 4.0 Technologies explores how cutting-edge technologies like artificial intelligence, big data, smart sensors, 3D printing, blockchain, and digital twins can drive the future of dairy. The book provides a thorough understanding of Industry 4.0 technologies and their applications, promoting sustainability through improved resource efficiency, waste reduction, and environmental impact. The book also offers practical insights and case studies demonstrating the impact of technology on dairy quality, safety, and traceability. Challenges such as high initial costs, data security concerns, technological integration complexities, regulatory and ethical issues, and resistance to change are addressed.Users will find this to be a resource that stimulates innovation by showcasing the latest research and developments, thus fostering a culture of continuous improvement. The book explores opportunities and hurdles, providing insights to drive the industry's transformation and helping to create conducive regulatory environments for technological adoption.…

Condición: New. Examines innovative treatment strategies, including antibodies, recombinant proteins, and vaccinesReviews the therapeutic potential of immune cells, gene therapy, and RNA interference in addressing various neurological conditionsHi.

Condición: New. pp. 396.

Paperback. Condición: Brand New. 350 pages. 7.52x0.85x9.25 inches. In Stock.

Hardcover. Condición: Brand New. 352 pages. 9.25x6.10x0.98 inches. In Stock.

Taschenbuch. Condición: Neu. Neuware - Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses explores the complex intersection of both the immune and nervous systems and neurological disorders. This comprehensive guide details the vital role of immunology in understanding conditions from Alzheimer's and Parkinson's to autoimmune diseases like multiple sclerosis and Guillain-Barré syndrome. Each chapter reviews strategies, including the use of antibodies, recombinant proteins, and cutting-edge vaccine approaches to modulate immune responses in the brain. Readers will be presented with the therapeutic potential of immune cells, gene therapy, and RNA interference in combating these debilitating disorders, while also examining the role of nanotechnology in enhancing treatment efficacy.Aimed at neurologists, immunologists, researchers, and students alike, this book serves as an essential resource for the latest advancements in neurological disease treatment.…

Hardcover. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Condición: new. Paperback. Immunotherapies for Neurological Disorders Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Paperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condición: New. 2026. 1st Edition. paperback. . . . . . Books ship from the US and Ireland.

Condición: New. 2026. 1st Edition. paperback. . . . . .

Condición: new. Questo è un articolo print on demand.

Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This bookaddresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant. 352 pp. Englisch.…

Gebunden. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Comprehensive book that discusses all the aspects of this class of drugs in relation to Parkinson s Disease Includes a review on the history of istradefylline Includes a review on urate as a biomarker and neuroprotectantComprehen.…

Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 352 pp. Englisch.…

Condición: New. PRINT ON DEMAND pp. 396.

Condición: New. Print on Demand pp. 396.